Shionogi celebrates antibiotic win in pneumonia just ahead of its date with FDA regulators

Just weeks before Shionogi is scheduled to hear back from the FDA on treating complicated urinary tract infections with its antibiotic, the Japanese pharma has another slate of positive data on a different indication to share.